Skin Cancer In Solid Organtransplant Recipients
暂无分享,去创建一个
S. Valiukevičienė | Mantas Kievišas | R. Vaičiūnienė | Lina Kievišienė | E. Vaitiekūnas | S. Kontautienė
[1] E. Huang,et al. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients , 2017, Transplantation.
[2] S. Kim,et al. Cancer Screening Recommendations for Solid Organ Transplant Recipients: A Systematic Review of Clinical Practice Guidelines , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] A. Green,et al. Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta‐Analysis , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] C. Schmults,et al. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer. , 2016, JAMA dermatology.
[5] H. Olsson,et al. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population‐based study , 2016, The British journal of dermatology.
[6] A. Green,et al. Increased risk of melanoma in organ transplant recipients: systematic review and meta-analysis of cohort studies. , 2015, Acta dermato-venereologica.
[7] S. Arron,et al. Melanoma risk and survival among organ transplant recipients , 2015, The Journal of investigative dermatology.
[8] B. Rozell,et al. Cutaneous malignant melanoma in the Swedish organ transplantation cohort: A study of clinicopathological characteristics and mortality. , 2015, Journal of the American Academy of Dermatology.
[9] S. Tyring,et al. Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients , 2015, Journal of clinical medicine.
[10] J. Fraumeni,et al. Risk of merkel cell carcinoma after solid organ transplantation. , 2015, Journal of the National Cancer Institute.
[11] G. Knoll,et al. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data , 2014, BMJ : British Medical Journal.
[12] S. Arron,et al. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation. , 2014, Journal of the American Academy of Dermatology.
[13] A. Webster,et al. Survival After Cutaneous Melanoma in Kidney Transplant Recipients: A Population‐Based Matched Cohort Study , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] J. Craig,et al. Donor Cancer Transmission in Kidney Transplantation: A Systematic Review , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] J. Bouwes Bavinck,et al. Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients: A Multicenter European Case Series , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] A. Weigert,et al. [Skin cancer in kidney transplant recipients: incidence and association with clinical and demographic factors]. , 2013, Acta medica portuguesa.
[17] L. Naldi,et al. Human Papillomavirus Load in Eyebrow Hair Follicles and Risk of Cutaneous Squamous Cell Carcinoma , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[18] Stanley J. Miller,et al. Therapeutic Options to Decrease Actinic Keratosis and Squamous Cell Carcinoma Incidence and Progression in Solid Organ Transplant Recipients: A Practical Approach , 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[19] E. Decullier,et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. , 2012, The New England journal of medicine.
[20] H. Bangash,et al. Management of Non-Melanoma Skin Cancer in Immunocompromised Solid Organ Transplant Recipients , 2012, Current Treatment Options in Oncology.
[21] G. Russ,et al. Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] M. Karczewski,et al. Skin cancer following kidney transplantation: a single-center experience. , 2011, Transplantation proceedings.
[23] Fiona O'Reilly Zwald,et al. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. , 2011, Journal of the American Academy of Dermatology.
[24] Fiona O'Reilly Zwald,et al. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. , 2011, Journal of the American Academy of Dermatology.
[25] A. Alba,et al. Long-term use of everolimus in lung transplant patients. , 2011, Transplantation proceedings.
[26] F. Zwald,et al. Management of Skin Cancer in Solid-organ Transplant Recipients: A Multidisciplinary Approach. , 2011, Dermatologic clinics.
[27] J. Reichrath. Dermatologic management, sun avoidance and vitamin D status in organ transplant recipients (OTR). , 2010, Journal of photochemistry and photobiology. B, Biology.
[28] H. Katus,et al. Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal. , 2010, Transplantation proceedings.
[29] R. Marcén,et al. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation. , 2010, Transplantation proceedings.
[30] M. Mahdavi-Mazdeh,et al. Skin cancer after renal transplantation: Results of a multicenter study in Iran. , 2010, Annals of transplantation.
[31] D. Lott,et al. Aggressive Behavior of Nonmelanotic Skin Cancers in Solid Organ Transplant Recipients , 2010, Transplantation.
[32] P. Karran,et al. Photo‐oxidation of 6‐Thioguanine by UVA: The Formation of Addition Products with Low Molecular Weight Thiol Compounds , 2010, Photochemistry and photobiology.
[33] R. Kaufmann,et al. Switch to a Sirolimus‐Based Immunosuppression in Long‐Term Renal Transplant Recipients: Reduced Rate of (Pre‐)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor‐Blinded, Controlled Clinical Trial , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[34] J. D. de Fijter,et al. Subsequent Squamous- and Basal-Cell Carcinomas in Kidney-Transplant Recipients After the First Skin Cancer: Cumulative Incidence and Risk Factors , 2010, Transplantation.
[35] A. Webster,et al. Long-term cancer risk of immunosuppressive regimens after kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.
[36] K. Mertz,et al. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features , 2010, International journal of dermatology.
[37] P. V. D. van der Boog,et al. Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients. , 2009, The Journal of investigative dermatology.
[38] D. Terhorst,et al. Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure , 2009, The British journal of dermatology.
[39] C. Vajdic,et al. Cancer incidence and risk factors after solid organ transplantation , 2009, International journal of cancer.
[40] A. Webster,et al. Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[41] C. Jiménez Romero,et al. Malignancy after liver transplantation: cumulative risk for development. , 2009, Transplantation proceedings.
[42] D. Nicol,et al. Predicting Risk of Nonmelanoma Skin Cancer and Premalignant Skin Lesions in Renal Transplant Recipients , 2009, Transplantation.
[43] N. Zeitouni,et al. Merkel cell carcinoma: a review of current advances. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.
[44] P. Karran,et al. Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions , 2009, Nucleic acids research.
[45] Jean Kanitakis,et al. Skin Cancer in Organ Transplant Recipients—Where Do We Stand Today? , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[46] R. A. Schwartz,et al. Kaposi sarcoma: a continuing conundrum. , 2008, Journal of the American Academy of Dermatology.
[47] P. Peduzzi,et al. Intensity of renal support in critically ill patients with acute kidney injury. , 2008, The New England journal of medicine.
[48] J. Bouwes Bavinck,et al. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine , 2008, Experimental dermatology.
[49] P. Moore,et al. Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.
[50] M. Falster,et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis , 2007, The Lancet.
[51] M. Gottschling,et al. Human Papillomaviruses and Non-Melanoma Skin Cancer: Basic Virology and Clinical Manifestations , 2007, Disease markers.
[52] E. Kay,et al. Genetic factors associated with skin cancer in renal transplant patients , 2007, Photodermatology, photoimmunology & photomedicine.
[53] P. Karran,et al. Novel DNA lesions generated by the interaction between therapeutic thiopurines and UVA light. , 2007, DNA repair.
[54] M. Lebwohl,et al. Chemoprevention of Nonmelanoma Skin Cancer with Systemic Retinoids: Practical Dosing and Management of Adverse Effects , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[55] J. Garcés,et al. Reduction of immunosuppression for transplant‐associated skin cancer: expert consensus survey , 2006, The British journal of dermatology.
[56] H. Comber,et al. A population‐based study of skin cancer incidence and prevalence in renal transplant recipients , 2006, The British journal of dermatology.
[57] B. Kahan,et al. Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies , 2005, Transplantation.
[58] P. Karran,et al. Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage , 2005, Science.
[59] L. Gesualdo,et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. , 2005, The New England journal of medicine.
[60] R. Gohh,et al. Localized cutaneous posttransplant Epstein-Barr virus-associated lymphoproliferative disorder. , 2004, Journal of the American Academy of Dermatology.
[61] A. Angelini,et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. , 2004, Archives of dermatology.
[62] P. Friend,et al. Two‐year incidence of malignancy in sirolimus‐treated renal transplant recipients: results from five multicenter studies * , 2004, Clinical transplantation.
[63] J. Carucci,et al. Guidelines for the Management of Squamous Cell Carcinoma in Organ Transplant Recipients , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[64] S. Euvrard,et al. Immunosuppressants and Skin Cancer in Transplant Patients: Focus on Rapamycin , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[65] D. Nicol,et al. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. , 2003, Journal of the American Academy of Dermatology.
[66] L. Kemény,et al. Skin cancers after organ transplantation. , 2003, The New England journal of medicine.
[67] Christine D. Brown,et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. , 2003, Archives of dermatology.
[68] R. Freeman,et al. Risk factors associated with the development of skin cancer after liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[69] D. Berg,et al. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. , 2002, Journal of the American Academy of Dermatology.
[70] U. Allen. Human herpesvirus type 8 infections among solid organ transplant recipients , 2002, Pediatric transplantation.
[71] I. Orengo,et al. Squamous cell carcinoma in solid-organ transplantation. , 2002, Dermatology online journal.
[72] G. Koehl,et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor , 2002, Nature Medicine.
[73] E. Woodle,et al. Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. , 2001, Transplantation proceedings.
[74] G. Thiene,et al. Skin Cancer in Heart Transplant Recipients: Risk Factor Analysis and Relevance of Immunosuppressive Therapy , 2000, Circulation.
[75] B. Kasiske,et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. , 2000, Journal of the American Society of Nephrology : JASN.
[76] Andrew G Smith,et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[77] M. Pittelkow,et al. Skin cancer in liver transplant recipients , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[78] M. Lagman,et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism , 1999, Nature.
[79] S Hansen,et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. , 1999, Journal of the American Academy of Dermatology.
[80] B. Dréno,et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens , 1998, The Lancet.
[81] B. O'Sullivan,et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. , 1996, Transplantation.
[82] I. Penn. Malignant melanoma in organ allograft recipients. , 1996, Transplantation.
[83] A. Dalgleish,et al. Kaposi's sarcoma. , 1991, British Journal of Cancer.
[84] Steve G Peters,et al. Incidence and risk factors for skin cancer following lung transplantation. , 2015, Journal of the American Academy of Dermatology.
[85] L. Naldi,et al. Human Papilloma Virus Load in Eyebrow Hair Follicles and Risk of Cutaneous Squamous Cell Carcinoma , 2013 .
[86] T. Weinstein,et al. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. , 2001, The Journal of laboratory and clinical medicine.